Is Brainsway Stock a Good Investment?

Brainsway Investment Advice

  BWAY
To provide specific investment advice or recommendations on Brainsway stock, we recommend investors consider the following general factors when evaluating Brainsway. This will help you to make an informed decision on whether to include Brainsway in one of your diversified portfolios:
  • Examine Brainsway's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
  • Research Brainsway's leadership team and their track record. Good management can help Brainsway navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
  • Consider the overall health of the Health Care Equipment & Supplies space and any emerging trends that could impact Brainsway's business and its evolving consumer preferences.
  • Compare Brainsway's performance and market position to its competitors. Analyze how Brainsway is positioned in terms of product offerings, innovation, and market share.
  • Check if Brainsway pays a dividend and its dividend yield and payout ratio.
  • Review what financial analysts are saying about Brainsway's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Brainsway stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Brainsway is a good investment.
 
Sell
 
Buy
Cautious Hold
Our trade advice tool can cross-verify current analyst consensus on Brainsway and to analyze the company potential to grow in the current economic cycle. To make sure Brainsway is not overpriced, please confirm all Brainsway fundamentals, including its cash and equivalents, beta, and the relationship between the price to sales and book value per share . Given that Brainsway has a shares owned by institutions of 32.12 %, we suggest you to validate Brainsway market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your prevailing risk tolerance and investing horizon.

Market Performance

ModestDetails

Volatility

Somewhat reliableDetails

Hype Condition

Low keyDetails

Current Valuation

UndervaluedDetails

Odds Of Distress

About AverageDetails

Economic Sensitivity

Almost mirrors the marketDetails

Investor Sentiment

AlarmedDetails

Analyst Consensus

Strong BuyDetails

Financial Strenth (F Score)

HealthyDetails

Financial Leverage

Not RatedDetails

Reporting Quality (M-Score)

Unlikely ManipulatorDetails

Examine Brainsway Stock

Researching Brainsway's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 32.0% of the company shares are held by institutions such as insurance companies. The book value of Brainsway was currently reported as 1.61. The company had not issued any dividends in recent years.
To determine if Brainsway is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Brainsway's research are outlined below:
Brainsway had very high historical volatility over the last 90 days
The company reported the previous year's revenue of 31.79 M. Net Loss for the year was (4.2 M) with profit before overhead, payroll, taxes, and interest of 30.58 M.
Latest headline from thelincolnianonline.com: Q1 Earnings Estimate for BrainsWay Issued By Northland Capmk

Brainsway Quarterly Liabilities And Stockholders Equity

72.1 Million

Brainsway uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Brainsway. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Brainsway's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
20th of March 2024
Upcoming Quarterly Report
View
15th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
20th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View
Earnings surprises can significantly impact Brainsway's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Brainsway's investors have experienced.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-11-13
2024-09-300.010.020.01100 
2023-11-15
2023-09-30-0.03-0.020.0133 
2023-08-09
2023-06-30-0.09-0.1-0.0111 
2022-03-09
2021-12-31-0.05-0.040.0120 
2020-11-18
2020-09-30-0.07-0.08-0.0114 
2024-03-06
2023-12-31-0.010.00760.0176176 
2025-03-04
2024-12-310.020.040.02100 
2024-05-08
2024-03-31-0.020.00670.0267133 

Brainsway Target Price Consensus

Brainsway target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Brainsway's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
   4  Strong Buy
Most Brainsway analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Brainsway stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Brainsway, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Brainsway Target Price Projection

Brainsway's current and average target prices are 10.10 and 13.72, respectively. The current price of Brainsway is the price at which Brainsway is currently trading. On the other hand, Brainsway's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Brainsway Market Quote on 20th of March 2025

Low Price10.1Odds
High Price10.1Odds

10.1

Target Price

Analyst Consensus On Brainsway Target Price

Low Estimate12.49Odds
High Estimate15.23Odds

13.725

Historical Lowest Forecast  12.49 Target Price  13.73 Highest Forecast  15.23
Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Brainsway and the information provided on this page.

Brainsway Analyst Ratings

Brainsway's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Brainsway stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Brainsway's financials, market performance, and future outlook by experienced professionals. Brainsway's historical ratings below, therefore, can serve as a valuable tool for investors.

Know Brainsway's Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Brainsway is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Brainsway backward and forwards among themselves. Brainsway's institutional investor refers to the entity that pools money to purchase Brainsway's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Legato Capital Management Llc2024-12-31
90.7 K
Zuckerman Investment Group, Llc2024-12-31
67 K
Two Sigma Advisers, Llc2024-12-31
60.6 K
Citadel Advisors Llc2024-12-31
32.1 K
Good Life Advisors, Llc2024-12-31
27.9 K
Ubs Group Ag2024-12-31
27.5 K
Jpmorgan Chase & Co2024-12-31
23.9 K
Rhumbline Advisers2024-12-31
22 K
Morgan Stanley - Brokerage Accounts2024-12-31
19.3 K
Valor Management Llc2024-12-31
2.1 M
Masters Capital Management Llc2024-12-31
1000 K
Note, although Brainsway's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Brainsway's market capitalization trends

The company currently falls under 'Small-Cap' category with a current market capitalization of 191.66 M.

Market Cap

103.96 Million

Brainsway's profitablity analysis

Last ReportedProjected for Next Year
Return On Tangible Assets(0.06)(0.06)
Return On Capital Employed(0.08)(0.09)
Return On Assets(0.06)(0.06)
Return On Equity(0.09)(0.10)
The company has Profit Margin (PM) of 0.07 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.04 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.04.
Determining Brainsway's profitability involves analyzing its financial statements and using various financial metrics to determine if Brainsway is a good buy. For example, gross profit margin measures Brainsway's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Brainsway's profitability and make more informed investment decisions.
Please note, the imprecision that can be found in Brainsway's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Brainsway. Check Brainsway's Beneish M Score to see the likelihood of Brainsway's management manipulating its earnings.

Evaluate Brainsway's management efficiency

Brainsway has return on total asset (ROA) of 0.0111 % which means that it generated a profit of $0.0111 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0562 %, meaning that it created $0.0562 on every $100 dollars invested by stockholders. Brainsway's management efficiency ratios could be used to measure how well Brainsway manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.06 in 2025. Return On Capital Employed is likely to drop to -0.09 in 2025. At this time, Brainsway's Non Currrent Assets Other are fairly stable compared to the past year. Total Current Assets is likely to rise to about 67 M in 2025, whereas Total Assets are likely to drop slightly above 42.3 M in 2025.
Last ReportedProjected for Next Year
Book Value Per Share 1.13  0.83 
Tangible Book Value Per Share 1.13  0.83 
Enterprise Value Over EBITDA(34.78)(33.04)
Price Book Value Ratio 3.01  2.86 
Enterprise Value Multiple(34.78)(33.04)
Price Fair Value 3.01  2.86 
Enterprise Value113.8 M87.4 M
Evaluating the management effectiveness of Brainsway allows investors to assess its financial health and operational efficiency. Coupled with an analysis of its growth prospects and the current market dynamics, we evaluate the stock's true value and future potential. Key indicators such as revenue, earnings or debt levels are examined alongside external factors like economic trends and regulatory changes. The Brainsway Stock analysis seeks to determine whether the stock is undervalued, appropriately priced, or overvalued, thereby guiding your investment decisions.
Beta
0.444

Basic technical analysis of Brainsway Stock

As of the 20th of March, Brainsway shows the mean deviation of 2.23, and Risk Adjusted Performance of 0.0262. Brainsway technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Brainsway's Outstanding Corporate Bonds

Brainsway issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Brainsway uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Brainsway bonds can be classified according to their maturity, which is the date when Brainsway has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Understand Brainsway's technical and predictive indicators

Using predictive indicators to make investment decisions involves analyzing Brainsway's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.

Consider Brainsway's intraday indicators

Brainsway intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Brainsway stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Brainsway Corporate Filings

6K
11th of March 2025
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify
28th of January 2025
Other Reports
ViewVerify
13A
14th of November 2024
An amended filing to the original Schedule 13G
ViewVerify
F3
13th of November 2024
The schedule filed by any person or group who acquires beneficial ownership of more than 5% of a voting class of a company's equity securities registered under Section 12 of the Act
ViewVerify
Brainsway time-series forecasting models is one of many Brainsway's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Brainsway's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Brainsway Stock media impact

Far too much social signal, news, headlines, and media speculation about Brainsway that are available to investors today. That information is available publicly through Brainsway media outlets and privately through word of mouth or via Brainsway internal channels. However, regardless of the origin, that massive amount of Brainsway data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Brainsway news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Brainsway relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Brainsway's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Brainsway alpha.

Brainsway Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Brainsway can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Brainsway Corporate Management

Additional Tools for Brainsway Stock Analysis

When running Brainsway's price analysis, check to measure Brainsway's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brainsway is operating at the current time. Most of Brainsway's value examination focuses on studying past and present price action to predict the probability of Brainsway's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brainsway's price. Additionally, you may evaluate how the addition of Brainsway to your portfolios can decrease your overall portfolio volatility.